Endpoint Health
PrivateLast Round
Series A
Jun 2, 2022
Est. Valuation
$2.14M
Total Funding Raised
$64.15M
Company Overview
Endpoint Health operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A round in June 2022.
Endpoint Health is a biotechnology company that develops precision therapies and therapy-guiding tests for patients with immune-driven critical and chronic illnesses.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endpoint Health Comparables
Compare Endpoint Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inflammatix | 77% | |
| Immunexpress | 76% | |
| Prenosis | 76% |
For institutional investors. Book with your work email.
Endpoint Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2022 | ||||
| Seed | Jul 13, 2020 | ||||
| Accelerator | Jan 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Endpoint Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Series A |
| YAYA Capital | Series A |
| Wireframe Ventures | Series A, Seed |
| Boom Capital | Series A |
| Alix Ventures | Series A |
| HCX Ventures | Series A |
| Humboldt Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2022
$52M round led by Mayfield Fund.
For institutional investors. Book with your work email.
Endpoint Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Endpoint Health's valuation, stock price, and market status.
Is Endpoint Health a public or private company?
Endpoint Health is a private company.
What is the current stock price of Endpoint Health?
Endpoint Health is a private company, so its shares have no public market price. Caplight tracks Endpoint Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endpoint Health worth (valuation)?
Endpoint Health's valuation is estimated at $2.1M based on funding round data.
Can I buy Endpoint Health stock?
Endpoint Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endpoint Health's last funding round?
Endpoint Health's most recent funding round was Series A on June 2, 2022.
Who are the main investors in Endpoint Health?
Key investors in Endpoint Health include Y Combinator, Mayfield Fund.
Will Endpoint Health IPO soon?
No public IPO plans have been announced for Endpoint Health.
How can I track Endpoint Health secondary market activity?
Caplight tracks bids, offers, and trades in Endpoint Health's shares on secondary markets.